Specificity and sodium dependence of the active nucleoside transport system in choroid plexus.
The transport of [3H]deoxyuridine by the active nucleoside transport system into the isolated rabbit choroid plexus was measured in vitro under various conditions. Choroid plexuses were incubated in artificial CSF containing 1 microM [3H]deoxyuridine and 1 microM nitrobenzylthioinosine for 5 min under 95% O2-5% CO2 at 37 degrees C and the accumulation of [3H]deoxyuridine measured. Nitrobenzylthioinosine was added to the artificial CSF at a concentration (1 microM) that did not inhibit the active nucleoside transport system but did inhibit the separate, saturable nucleoside efflux system. The active transport of deoxyuridine into the choroid plexus depended on Na+ in the medium, as ouabain, substitution of Li+ and choline for Na+, and poly-L-lysine all inhibited deoxyuridine transport. Thiocyanate in place of chloride and penetrating sulfhydryl reagents also inhibited the active transport of deoxyuridine into choroid plexus. The active transport of deoxyuridine into choroid plexus, which is inhibited by naturally occurring ribo- and deoxyribonucleosides (IC50 = 7-21 microM), was not inhibited (IC50 much greater than 150 microM) by nucleosides with certain alterations on the 2', 3', or 5' positions in D-ribose or 2-deoxy-D-ribose (e.g., adenine arabinoside, 3'-deoxyadenosine, xylosyladenosine); or the pyrimidine or purine rings (e.g., 6-azauridine, xanthosine, 7-methylinosine, or 8-bromoadenosine). Other analogues were effective (IC50 = 8-26 microM; e.g., 5-substituted pyrimidine nucleosides, 7-deazaadenosine, 6-mercaptoguanosine) or less effective (IC50 = 46-145 microM; e.g., 5-azacytidine, 3-deazauridine) inhibitors of deoxyuridine transport into the isolated choroid plexus.
D000818:Animals; D001693:Biological Transport, Active; D002831:Choroid Plexus / Q000378:metabolism*; D003857:Deoxyuridine / Q000378:metabolism; D005033:Ethylmaleimide / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D009705:Nucleosides / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology; D011107:Polylysine / Q000494:pharmacology; D011817:Rabbits; D012964:Sodium / Q000378:metabolism*; D013329:Structure-Activity Relationship
D009539:Nicotinic Acids; D009705:Nucleosides; C001102:6,6'-dithiodinicotinic acid; D011107:Polylysine; D010042:Ouabain; D012964:Sodium; D005033:Ethylmaleimide; D003857:Deoxyuridine